Thomas Hunter, MD
Ophthalmology · Durham, NCNPI 1871702530
Payments from drug & device makers
Across 38 payments — averaging $173.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$4K
- Glaukos Corporation$533
- Nova Eye, Inc.$280
- Alcon$255
- Bausch & Lomb Americas Inc.$233
- Quidel Corporation$214
- plus $694 from 7 others
What the payments were for
- Consulting fees$2,50038%
- Travel & lodging$1,24019%
- Food & beverage$2,84643%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 17 | $4,378 |
| Glaukos Corporation | 7 | $533 |
| Nova Eye, Inc. | 1 | $280 |
| Alcon | 2 | $255 |
| Bausch & Lomb Americas Inc. | 2 | $233 |
| Quidel Corporation | 1 | $214 |
| Amgen | 2 | $206 |
| Microsurgical Technology, Inc. | 1 | $133 |
| Sight Sciences, Inc. | 1 | $122 |
| Aerie Pharmaceuticals, Inc. | 1 | $100 |
| NEW World Medical,inc. | 1 | $72 |
| AbbVie | 1 | $50 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$3,033
- Tecnis 3-piece IOL$3,033
- Tecnis Symfony IOL$1,533
- Tecnis Symfony Toric IOL$1,533
- Catalys Laser System$1,500
- Unfolder IOL Delivery Systems$1,500
- Eye Health$641
- MIEBO$233
- XIIDRA$233
- iStent infinite Trabecular Micro-Bypass System Model iS3$183
- iAccess Precision Blade$183
- iPRIME Viscodelivery System$183
- iStent$170
- iStent inject W$170
- IACCESS$170
- ARGOS$137
- OMNI(R) SURGICAL SYSTEM (US)$122
- SION SURGICAL INSTRUMENT$122
- PanOptix$118
- Rhopressa$100
How this compares
$6,586 in reported general payments places this provider in the 80th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RhopressaNetarsudil Mesylate | 154 | $68,118 |
| RestasisCyclosporine | 52 | $54,638 |
| LumiganBimatoprost | 97 | $47,429 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 63 | $21,647 |
| Latanoprost | 1,324 | $15,509 |
| RocklatanNetarsudil Mesylat/Latanoprost | 23 | $15,332 |
| CombiganBrimonidine Tartrate/Timolol | 35 | $14,593 |
| Alphagan PBrimonidine Tartrate | 27 | $14,173 |
| Travoprost | 74 | $11,145 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 686 | $11,128 |
| Prednisolone Acetate | 299 | $10,404 |
| Timolol Maleate | 215 | $9,442 |
| Brimonidine Tartrate | 522 | $9,282 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 50 | $8,929 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 31 | $5,355 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $50 | $130,834211 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $100 | $83,450177 claims |
| AlconSimbrinza | $255 | $21,64763 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 588 ophthalmology providers in North Carolina.
Other ophthalmology in Durham
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Majda HadziahmetovicDurham$2.4M
- Julie WoodwardDurham$1M
- Terry KimDurham$605K
- Anthony KuoDurham$392K
- Leon HerndonDurham$350K
- Robin VannDurham$213K
- Michael RichardDurham$113K
- Priyatham MettuDurham$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.